J, M., A, C., S, P., A, L., E, M., C, V., . . . C, d. T. (2017). GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
Citación estilo ChicagoJ, Mora, et al. GEIS-21: A Multicentric Phase II Study of Intensive Chemotherapy Including Gemcitabine and Docetaxel for the Treatment of Ewing Sarcoma of Children and Adults: A Report From the Spanish Sarcoma Group (GEIS). 2017.
Cita MLAJ, Mora, et al. GEIS-21: A Multicentric Phase II Study of Intensive Chemotherapy Including Gemcitabine and Docetaxel for the Treatment of Ewing Sarcoma of Children and Adults: A Report From the Spanish Sarcoma Group (GEIS). 2017.